Page last updated: 2024-10-22

albuterol and Long QT Syndrome

albuterol has been researched along with Long QT Syndrome in 4 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"Latent forms of long QT syndrome have been already reported."1.30[Latent long QT syndrome: discription of a clinical case]. ( Bianconi, L; Castro, A; Pandozi, C; Santini, M; Toscano, S, 1997)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aliaga, CA1
Arizon, LF1
Bermúdez, RM1
Castán, JAB1
Santandreu, AV1
Williams, C1
Finn, AF1
Thompson, CM1
Banov, CH1
O'Connor, BK1
Case, CL1
Castro, A1
Pandozi, C1
Bianconi, L1
Toscano, S1
Santini, M1

Other Studies

4 other studies available for albuterol and Long QT Syndrome

ArticleYear
Severe hypokalemia secondary to abuse of β-adrenergic agonists in a pediatric patient: Case report.
    Jornal brasileiro de nefrologia, 2019, May-30, Volume: 42, Issue:2

    Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Drug Overdose; Factitious Disorders; Humans; Hypoka

2019
Cause of death in the SMART Trial.
    Chest, 2006, Volume: 130, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Black or African American; Cause of Death; Dose-Respons

2006
Beta2-agonist induced ventricular dysrhythmias secondary to hyperexcitable conduction system in the absence of a long QT syndrome.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1997, Volume: 78, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Beclomethasone; Child; Electrocardiog

1997
[Latent long QT syndrome: discription of a clinical case].
    Giornale italiano di cardiologia, 1997, Volume: 27, Issue:4

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Electrocardiography;

1997